RAC 1.51% $1.64 race oncology ltd

Ann: Bisantrene Phase 2 AML Trial Successful Concludes, page-9

  1. 131 Posts.
    lightbulb Created with Sketch. 57
    Been on the side-lines for a little while now due to some personal reasons but very happy to say I'm back on board after this announcement.

    Was always nervous that this was going to take off without me, thankfully it's still a sleeping giant...

    Great announcement that can only have one feeling more confident in an already amazing drug.

 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.